Avant Immunotherapeutics 1Q loss widens on charge (AP via Yahoo! Finance)
Biotechnology company Avant Immunotherapeutics Inc. said Monday its first-quarter loss widened on buyout charges. The company recorded a loss of $22.1 million, or $2.19 per share, compared with a loss of $4 million, or 49 cents per share, during the same period a year prior.
This entry was posted
on Monday, May 19th, 2008 at 6:01 pm and is filed under After Hours Stock Market News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.